BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Amazon
AMZN
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$345M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$322M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$302M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
+$343M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$308M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$301M |
| 4 |
IAC Inc
IAC
|
+$203M |
| 5 |
Visa
V
|
+$176M |
Sector Composition
| 1 | Technology | 17.42% |
| 2 | Consumer Discretionary | 10.68% |
| 3 | Healthcare | 7.66% |
| 4 | Financials | 7.63% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Pulse Biosciences
PLSE
$966M
| $51K | ﹤0.01% |
4,323
+3,073
| +246% | +$36.2K |
|
2702
REV Group
REVG
$3.07B
| $50.9K | ﹤0.01% |
6,447
+4,862
| +307% | +$38.4K |
|
|
ASPU
2703
DELISTED
ASPEN GROUP, INC.
ASPU
| $50.8K | ﹤0.01% |
4,551
+3,856
| +555% | +$43.1K |
|
|
CHMA
2704
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $50.8K | ﹤0.01% |
11,819
+10,328
| +693% | +$44.4K |
|
2705
Atlanta Braves Holdings Series A
BATRA
$2.86B
| $50.8K | ﹤0.01% |
2,432
+2,008
| +474% | +$41.9K |
|
2706
Liquidity Services
LQDT
$854M
| $50.8K | ﹤0.01% |
6,805
+5,326
| +360% | +$39.7K |
|
|
RVI
2707
DELISTED
Retail Value Inc. Common Shares
RVI
| $50.7K | ﹤0.01% |
43,926
-6,384
| -13% | -$7.37K |
|
|
CPLG
2708
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $50.7K | ﹤0.01% |
9,295
-1,730
| -16% | -$9.43K |
|
|
AD
2709
Array Digital Infrastructure, Inc.
AD
$4.42B
| $50.5K | ﹤0.01% |
1,710
-7,471
| -81% | -$221K |
|
2710
Red River Bancshares
RRBI
$433M
| $50.4K | ﹤0.01% |
1,172
+993
| +555% | +$42.7K |
|
|
PRTK
2711
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $50.4K | ﹤0.01% |
9,307
+7,222
| +346% | +$39.1K |
|
2712
Veritone
VERI
$216M
| $50.3K | ﹤0.01% |
5,495
+4,634
| +538% | +$42.4K |
|
2713
Rayonier Advanced Materials
RYAM
$416M
| $50.3K | ﹤0.01% |
15,727
+10,964
| +230% | +$35.1K |
|
2714
ImmunityBio
IBRX
$2.46B
| $50.1K | ﹤0.01% |
7,231
+6,070
| +523% | +$42.1K |
|
2715
Metropolitan Bank Holding Corp
MCB
$813M
| $50K | ﹤0.01% |
1,786
+1,377
| +337% | +$38.6K |
|
|
CONN
2716
DELISTED
Conn's Inc.
CONN
| $49.1K | ﹤0.01% |
4,638
+3,467
| +296% | +$36.7K |
|
2717
Bridgewater Bancshares
BWB
$455M
| $49K | ﹤0.01% |
5,159
+3,975
| +336% | +$37.7K |
|
|
CKPT
2718
DELISTED
Checkpoint Therapeutics
CKPT
| $48.8K | ﹤0.01% |
1,821
+885
| +95% | +$23.7K |
|
2719
Farmers & Merchants Bancorp
FMAO
$361M
| $48.7K | ﹤0.01% |
2,434
+1,871
| +332% | +$37.4K |
|
|
HT
2720
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $48.7K | ﹤0.01% |
8,785
+4,402
| +100% | +$24.4K |
|
2721
Novo Nordisk
NVO
$244B
| $48.6K | ﹤0.01% |
1,400
-214
| -13% | -$7.43K |
|
2722
Oppenheimer Holdings
OPY
$809M
| $48.5K | ﹤0.01% |
2,174
+1,812
| +501% | +$40.4K |
|
2723
Village Super Market
VLGEA
$582M
| $48.5K | ﹤0.01% |
1,969
+1,659
| +535% | +$40.8K |
|
|
RUBY
2724
DELISTED
Rubius Therapeutics, Inc
RUBY
| $48.3K | ﹤0.01% |
9,646
+7,047
| +271% | +$35.3K |
|
2725
Pure Cycle
PCYO
$269M
| $48.3K | ﹤0.01% |
5,363
+2,961
| +123% | +$26.7K |
|